Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization

Linzhi Wei(China Pharmaceutical University), Na Lu(Shandong Maternal and Child Health Hospital)

Cell Death and Disease

April 9, 2015

10.1038/cddis.2015.86

Cited by 87

Related Papers

Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma

|Cell Death and Disease|2013|137

Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer

|Journal of Experimental & Clinical Cancer Research|2018|93

Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway

|Oncotarget|2016|55

Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer

|Journal of Experimental & Clinical Cancer Research|2017|55

Anti-invasive effect of gambogic acid in MDA-MB-231 human breast carcinoma cells

|Biochemistry and Cell Biology|2008|53